Anonymous ID: 3b770c July 26, 2021, 7:23 p.m. No.14205534   🗄️.is đź”—kun   >>5599 >>5648

https://nypost.com/2021/07/15/parkland-shooter-nikolas-cruz-attacks-jail-guard-in-new-video/

Shocking video shows accused Parkland school shooter attack jail officer

Shocking new surveillance video shows the moment accused Parkland school shooter Nikolas Cruz attacks an officer at the Broward County Jail in 2018 — some nine months after the deadly shooting spree that left 17 dead.

Cruz, who is charged with first-degree murder in the Feb. 14, 2018, shooting at Marjory Stoneman Douglas High School, is seen walking in circles in the jail cafeteria, according to footage posted on YouTube by Law & Crime.

After several minutes, Cruz is seen speaking to the guard, identified as Sgt. Raymond Beltran, who is sitting in the corner of the cafeteria.

The Nov. 13, 2018, video has no audio, but the accused killer is seen giving the officer the finger before lunging at him and wrestling him to the floor while swinging at him.

Beltran ultimately slugs Cruz, who walks to the other side of the room and lies face-down on the floor after the guard pulls out a stun gun, the footage shows.

The video was played by prosecutors in court Wednesday at Cruz’s first in-person court appearance since the outbreak of the coronavirus pandemic.

In stark contrast to the video attack, Cruz, shackled and in an orange jumpsuit, sat quietly throughout the 30-minute court appearance.

Defense attorney David Wheeler told Circuit Judge Elizabeth Sherer that Beltran had previously mistreated Cruz and he was reacting to the abuse.

Prosecutor Maria Schneider asked the judge for complete medical records for Cruz to determine if they back up claims of abuse by Beltran.

Wheeler countered that the records are largely confidential.

Sherer is scheduled to rule on the request on Friday.

Cruz, 22, faces a possible death sentence if convicted in the bloody shooting, among the deadliest in US history.

Anonymous ID: 3b770c July 26, 2021, 8:07 p.m. No.14205811   🗄️.is đź”—kun   >>5821 >>5826 >>5833

https://mologic.co.uk/mologic-to-become-a-social-enterprise-after-acquisition-by-social-impact-funders-and-investors/

 

A group of philanthropic funds and investors led by the Soros Economic Development Fund (SEDF), with support from the Bill & Melinda Gates Foundation, is today announcing the launch of Global Access Health (GAH), a social enterprise that will seek to expand access to affordable state-of-the-art medical technology through decentralized research, development, and manufacturing in and for the Global South.

The group has financed the acquisition of Mologic Ltd, a world leading innovator in the development of lateral flow and rapid diagnostic technologies including tests that can help combat tropical diseases such as dengue, bilharzia, and river blindness, as well as for COVID-19.

The members of GAH will invest at least ÂŁ30 million ($41 million) in this deal.

The transaction is important in that it transitions a world-class for-profit company into a social enterprise and allows it to entirely reinvest its profits in pursuing these goals. This transformation will give it the ability to address gaps in the provision of global diagnostics in low-income communities and regions that profit-focused business has failed to address.

SEDF is the impact investment arm of the Open Society Foundations. Sean Hinton, SEDF’s Chief Executive Officer, said: “The COVID-19 pandemic has painfully demonstrated the fundamental inequities in global public health, and in particular the crucial importance of access in low- and middle-income countries to low-price, high-quality life-saving diagnostic tools. In this unique transaction, philanthropic funds and investors are working together with a skilled and visionary management team in a truly innovative way to address at least one part of that failure by enabling a cutting edge commercial business to focus all its resources on solving one of the world’s most pressing public health issues.”

Mologic was established in 2003 by Mark Davis and his father Professor Paul Davis, one of the original creators of ClearBlue, the world’s first home pregnancy test. Mologic’s technology has broad application across markets and disease states where rapid, accurate point-of-need testing can help make a significant difference in patient care and patient outcomes. Its extensive work in developing affordable testing for neglected tropical diseases has been supported by grant funding from a range of donors, and most significantly by the Bill & Melinda Gates Foundation.

Anonymous ID: 3b770c July 26, 2021, 8:08 p.m. No.14205821   🗄️.is đź”—kun   >>5853

>>14205811

 

Mark Davis, CEO of Mologic, welcomed the conclusion of the deal: “Mologic’s transition into a social enterprise is a deliberate, logical and natural step for a company focused on delivering affordable diagnostics and biotechnology to places that have been left underserved by the relentless pursuit of profiteering. With the support of our shareholders, donors and partners we have come a long way; we believe we have the people and the skills required for the challenges and opportunities ahead. And we hope this unique transaction will be an example for others to follow.”

“Testing, or diagnostics, are vital for every day public health needs, to enable doctors and medical professionals to provide patients with proper treatment as early as possible,” said Roxana Bonnell, a public health expert at the Open Society Foundations. “As we have seen during the COVID-19 pandemic, access to testing is absolutely essential when it comes to containing the spread of contagious disease—an issue that ultimately affects us all.”

As part of the transaction GAH will integrate both Mologic and a sister non-profit entity, Global Access Diagnostics (GAD), which was established by the founders of Mologic with support from SEDF, the UK’s DFID and others in April 2020. GAD is focused on low-cost manufacturing of diagnostic tests, and licenses Mologic’s technology in Africa and South Asia. Mark Davis will continue to serve as CEO of Mologic, with Paul Davis continuing as Chief Scientific Officer. GAD will continue as a separate non-profit entity, under CEO Mark Radford. Both will be wholly-owned and governed by GAH. A number of other philanthropic funds and investors are currently engaged in finalizing their participation in GAH to further the scope and ambition of the organisation.

The transaction involves the acquisition by the investing consortium of all Mologic’s existing shares, including those held by two private investment managers, Foresight Group LLP, and Calculus Capital.

SEDF’s investments in GAH and GAD are part of a portfolio of recent investments made in service of Open Society Foundations’ commitment to expand global access to affordable, quality public health products and technologies. These investments build on two decades of foundation support for improved access to medicines advocacy and policy making globally.

The Open Society Foundations, founded by its chairman George Soros, is the world’s largest private funders of human rights and social justice advocacy groups. The Soros Economic Development Fund, established in 1997, pursues impact investments that are aligned with Open Society’s broader mission, and currently holds 35 investments totaling c.$300m.

Anonymous ID: 3b770c July 26, 2021, 8:11 p.m. No.14205837   🗄️.is đź”—kun   >>5848 >>5858

https://mologic.co.uk/mologic-partners-with-finddx-for-schistosomiasis-rapid-test/

Mologic partners with FINDdx for schistosomiasis rapid test

Mologic and Neglected Diseases

Bedfordshire, UK, May 13 2021: Neglected Tropical Diseases affect more than one billion people worldwide, in some of the poorest areas. According to the World Health Organisation, schistosomiasis is a disease of poverty that leads to chronic ill health and affects nearly 240m people. Moreover, an estimated 700m people live in endemic areas. Mologic has partnered with FINDdx to develop a rapid test for schistosomiasis.

Since 2018, Mologic has increased its focus on epidemics and neglected diseases now addressing 14 Targets, supported by the Bill & Melinda Gates Foundation, the Wellcome Trust, the UK government, and the Foundation for Innovative New Diagnostics (FIND). For more information about Mologic’s epidemic and neglected diseases diagnostic tests, please click here.

https://mologic.co.uk/our-core-markets-and-products/global-health/